Park Medi World Q2 FY'27 Revenue Surges 25% to ₹511 Crore, H1 Revenue at ₹987 Crore
Park Medi World reported record H1 FY'27 revenue of ₹987 crore, up 22% YoY, with Q2 FY'27 revenue at ₹511 crore, up 25% YoY. The company added 680 beds in H1 FY'27, reaching 4,290 beds, and plans to add 1,430 beds in FY'27. H1 FY'27 Net Profit was ₹143 crore, flat YoY.
The announcement details significant financial performance metrics (record revenue growth) and substantial strategic expansion plans (acquisitions, new facility commissioning), which are material to investors and the company's future outlook.
The company reported record revenue growth in both Q2 and H1 FY'27, alongside significant capacity expansion, indicating positive business momentum. While net profit saw a decline in Q2, the overall strategic expansion and revenue figures are positive.
Park Medi World Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported a record revenue of ₹9,867 million (₹987 crore) for H1 FY'27, marking a 22% year-on-year increase. For the second quarter of FY'27, revenue grew by 25% to ₹5,110 million (₹511 crore), also a record high.
The company treated over half a million patients in H1 FY'27 and expanded its bed capacity by 19% in six months, adding 680 beds. The total bed capacity reached 4,290 beds as of September 30, 2026. Significant expansion plans include the acquisition of 'Mehar Hospital' (150 beds) in Zirakpur, expected to be commissioned in December 2026, and an Operations and Management arrangement for a 300-bed hospital in Kanpur, expected in Q4 FY'27. The company anticipates commissioning a total of 1,430 beds in FY'27, a 40% increase over FY'26 capacity.
Despite the revenue growth, EBITDA for H1 FY'27 was ₹2,278 million (₹228 crore), up 5% YoY, with an EBITDA margin of 23.1%. Net profit for H1 FY'27 was ₹1,431 million (₹143 crore), flat YoY, with a net profit margin of 14.5%. For Q2 FY'27, Net Profit was ₹545 million (₹54.5 crore), down 31% YoY, with a margin of 10.7%. The company highlighted that onboarding new capacity has had a near-term impact on occupancy and profitability. Park Medi World maintains strong liquidity with ₹3,713 million (₹371.3 crore) in cash and cash equivalents against term debt of ₹1,779 million (₹177.9 crore).
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.